Mergers & Acquisitions Mergers & Acquisitions

Hypera-Sanofi deal faces more scrutiny in Brazil after being declared 'complex'

By Ana Paula Candil
  • 20 Dec 2021 16:18
  • 20 Dec 2021 16:18
Hypera's planned buyout of 12 medicine brands from Sanofi Medley Farmacêutica has been declared "complex" by the Brazilian competition authority and will require an in-depth analysis because of what the agency deemed high concentration levels in certain markets.

They include stimulant laxatives and prescription nasal decongestants.

"During the market test, several competitors and clients

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News